Pharvaris (PHVS) Free Cash Flow Growth (1y) (2021 - 2026)
Pharvaris (PHVS) Free Cash Flow Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,583.17 Bn | 67,582.89 Bn | - | 7.12% |
| 2 | Nanobiotix | 1,947.22 Bn | 1,947.15 Bn | - | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | - |
| 4 | BeOne Medicines | 473.21 Bn | 468.42 Bn | 1.35 Bn | 1,092.51% |
| 5 | Vertex Pharmaceuticals | 123.29 Bn | 116.04 Bn | 2.59 Bn | 66.37% |
| 6 | Regeneron Pharmaceuticals | 70.05 Bn | 61.29 Bn | 3.31 Bn | 3.98% |
| 7 | Belite Bio | 63.09 Bn | 63.09 Bn | - | - |
| 8 | Argenx Se | 56.63 Bn | 51.45 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.79 Bn | 37.79 Bn | - | - |
| 10 | Pharvaris | 2.23 Bn | 1.94 Bn | - | -41.52% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -41.52% |
| Dec 31, 2025 | -18.82% |
| Sep 30, 2025 | 1.00% |
| Jun 30, 2025 | -14.07% |
| Mar 31, 2025 | -53.28% |
| Dec 31, 2024 | -45.31% |
| Sep 30, 2024 | -100.00% |
| Jun 30, 2024 | 100.00% |
| Mar 31, 2024 | 2.74% |
| Dec 31, 2023 | -23.00% |
| Sep 30, 2023 | 325,629,580.06% |
| Jun 30, 2023 | -340,811,256.10% |
| Mar 31, 2023 | -34.90% |
| Dec 31, 2022 | -46.24% |
| Sep 30, 2022 | -29.24% |
| Jun 30, 2022 | -2.29% |
| Mar 31, 2022 | -63.04% |
| Dec 31, 2021 | -34.00% |
| Sep 30, 2021 | -52.98% |
| Jun 30, 2021 | -255.90% |